Germitec SAS

Germitec SAS

Leading the way in chemical free and ultrafast automated high level disinfection for reprocessing ultrasound probes. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€44—66m (Dealroom.co estimates May 2022.)
Company register number 484531199
Ivry-sur-Seine Île-de-France (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

€11.0m

Early VC
Total Funding€11.0m

Recent News about Germitec SAS

Edit
More about Germitec SASinfo icon
Edit

Germitec specializes in providing UV-C high-level disinfection (HLD) solutions specifically designed for reprocessing non-lumen ultrasound probes. The company operates in the healthcare sector, focusing on infection prevention and control. Its primary clients include hospitals, clinics, and medical facilities that utilize ultrasound technology. Germitec's business model revolves around the sale and maintenance of its disinfection devices, which are chemical-free and eco-friendly, ensuring safety for both medical staff and patients. The company generates revenue through the direct sale of its products and ongoing service contracts. Germitec's technology is recognized for its simplicity, efficiency, and effectiveness, having won awards such as the Prix Galien for Best Medical Device. The market for Germitec's products is driven by the increasing need for stringent infection control measures, especially in the wake of global health concerns like COVID-19.

Keywords: UV-C disinfection, ultrasound probes, infection control, healthcare, medical devices, eco-friendly, chemical-free, patient safety, award-winning, efficiency.